Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-11 12:05 pm Purchase | 2022-09-30 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 588,235 38.700% | 588,235 (New Position) | Filing History |
| 2022-10-07 12:46 pm Purchase | 2022-09-14 | 13G | BENITEC BIOPHARMA INC BNTC | Oliveira Steven Michael | 122,598 8.080% | 83,297 (+211.95%) | Filing History |
| 2022-09-23 10:11 am Purchase | 2022-09-13 | 13G | BENITEC BIOPHARMA INC BNTC | CVI Investments, Inc. | 88,235 5.800% | 88,235 (New Position) | Filing History |
| 2022-02-10 09:09 am Unchanged | 2021-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% | 0 (Unchanged) | Filing History |
| 2022-02-10 09:07 am Unchanged | 2021-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% | 0 (Unchanged) | Filing History |
| 2022-02-09 4:39 pm Purchase | 2021-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% | 34,559 (New Position) | Filing History |
| 2022-02-08 4:31 pm Sale | 2021-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | Hudson Bay Capital Management LP | 0 0.000% | -21,034 (Position Closed) | Filing History |
| 2022-01-13 10:53 am Sale | 2021-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | Alpha Capital Anstalt | 7,333 1.530% | -7,742 (-51.36%) | Filing History |
| 2021-05-07 4:46 pm Purchase | 2021-04-28 | 13G | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | 45,235 9.800% | 45,235 (New Position) | Filing History |
| 2021-04-28 5:22 pm Purchase | 2021-04-28 | 13G | BENITEC BIOPHARMA INC BNTC | Lincoln Park Capital Fund LLC | 24,913 5.392% | 24,913 (New Position) | Filing History |